The Endocrine Society recommends
primary aldosterone screening for people who meet one of the following criteria:
Not exact matches
A late - breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an
Aldosterone Antagonist (TOPCAT) trial, to be presented at the American Heart Association (AHA) Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the
primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump function).
People who have
primary adrenal insufficiency and a confirmed
aldosterone deficiency should undergo replacement therapy — typically with the synthetic hormone fludrocortisone — to maintain the body's salt and water balance.
When the increase of
aldosterone is caused by a problem in your adrenals, the condition is called
primary aldosteronism.
Reduced secretion of
aldosterone (a steroid hormone secreted by the Adrenal Cortex); which is the
primary mineralocorticoid of the adrenal glands can cause a severe imbalance of minerals in the body; such as potassium, chloride and sodium.